Researchers at Case Western Reserve University School of Medicine have developed a method that could make magnetic resonance imaging—MRI—multicolor.
Current MRI techniques rely on a single contrast agent injected into a patient’s veins to vivify images. The new method uses two at once, which could allow doctors to map multiple characteristics of a patient’s internal organs in a single MRI. The strategy could serve as a research tool and even aid disease diagnosis.
“The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents,” said Chris Flask, PhD, Associate Professor of Radiology, Biomedical Engineering, and Pediatrics, and Director of the Imaging Resource Core at Case Western Reserve University School of Medicine. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example. The new method would enable immediate comparisons of how each agent distributes in the same patient.
“This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients,” said Flask. It also provides a unique imaging platform to rigorously study molecular therapies.” Therapies could include those targeting biomarkers or other detectable molecules associated with diseases.
Flask and colleagues recently described their new method in Nature Scientific Reports. The paper describes how two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs. The authors span 11 departments at Case Western Reserve, uniting engineers, nurses, clinicians, and basic science researchers. They also include several members of the Case Comprehensive Cancer Center. According to the authors, their results provide “an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications.”
The researchers have begun to investigate widespread practical applications for the new MRI approach. Said Flask, “In this initial paper, we validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes.”
Learn more: Multicolor MRIs Could Aid Disease Detection
The Latest on: Multicolor MRIs
- Stelter, Wagner highlight a prevalent ACL riskon June 25, 2020 at 7:51 am
Ava Stelter was getting ready to go to personal therapy to rehabilitate her knee after tearing her anterior cruciate ligament when she saw it.
- Healthcare embraces the cloud for data management, storage and scalabilityon June 24, 2020 at 10:09 am
Scality Inc, a company that provides storage software with capabilities within the cloud through products like Ring and Zenko , is helping healthcare organizations rapidly pivot during an ...
- AMRA Medical Presents Reproducibility Study of an MRI-based Body Composition Analysis Methodon June 23, 2020 at 6:32 am
AMRA's recent study, in collaboration with Linköping University, shows between-scanner reproducibility and within-scanner repeatability of ...
- Focal white matter disruptions along the cingulum tract explain cognitive decline in amnestic mild cognitive impairment (aMCI)on June 23, 2020 at 2:12 am
White matter abnormalities of the human brain are implicated in typical aging and neurodegenerative diseases. However, our understanding of how fine-grained changes in microstructural properties along ...
- Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomason June 22, 2020 at 12:27 pm
FLAIR mismatch sign is known as a highly specific imaging marker of IDH-mutant astrocytomas. This study was intended to clarify what the T2-FLAIR mismatch sign represents by pathological analysis of ...
- Multi-institutional study examines neuroimaging findings in COVID-19 patientson June 16, 2020 at 4:48 pm
A new multi-institutional study published in the journal Radiology identifies patterns in abnormal brain MRI findings in patients with COVID-19. Current data on central nervous system (CNS) ...
- MRI Pinpoints Non-Stroke Abnormal Brain Findings in COVID-19-Positive Patientson June 16, 2020 at 12:48 pm
Patients with COVID-19 infection display abnormal brain findings other than stroke on MRI, new research has revealed. Published on June 16 in Radiology, data from a multi-institution study revealed ...
- Multi-institutional study looks at brain MRI findings in COVID-19on June 16, 2020 at 9:39 am
A new multi-institutional study published in the journal Radiology identifies patterns in abnormal brain MRI findings in patients with COVID-19.
- New MRI Methods Could Improve Treatment for Tremor and Parkinson’son June 15, 2020 at 8:25 am
Newly developed MRI techniques can help neuroradiologists more effectively target and treat the area of the brain responsible for tremors in patients living with Parkinson’s disease, leading to better ...
- Magnetic Resonance Imaging Devices And Equipment Market Size, Status, Global Outlook 2020 To 2030on June 8, 2020 at 6:38 am
The advanced MRI systems such as Multi contract MRI scanners, silent MRI Scanning technologies, and others allow radiologists to modify patient’s image contrast after scanning, which is not ...
via Google News and Bing News